Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate safety, tolerability, and pharmacokinetics of VX-828 and VX-828 in triple combination (TC) with Tezacaftor (TEZ)/ VX-118 or TEZ/ deutivacaftor (D-IVA) in health...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vertex Pharmaceuticals Incorporated
NCT02417740 · Cystic Fibrosis, Immunologic Deficiency Syndrome, and more
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT04530383 · Cystic Fibrosis-related Diabetes, Cystic Fibrosis
NCT05422222 · Cystic Fibrosis
NCT06984679 · Cystic Fibrosis (CF), Cystic Fibrosis in Children
Joe DiMaggio Cycstic Fibrosis & Pulmonary Center
Hollywood, Florida
AdventHealth Medical Group Pulmonology at Orlando Ridgewood
Orlando, Florida
Altasciences Clinical Kansas
Overland Park, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions